Peter L. Hoang - 24 Mar 2022 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
President and CEO, Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Issuer symbol
MRKR
Transactions as of
24 Mar 2022
Net transactions value
-$23,453
Form type
4
Filing time
28 Mar 2022, 21:06:03 UTC
Previous filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRKR Common Stock Award $0 +199,094 +60% $0.000000 531,662 24 Mar 2022 Direct F1
transaction MRKR Common Stock Tax liability $23,453 -48,376 -9.1% $0.4848 483,286 24 Mar 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award.
F2 Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs.